Search results
Results from the WOW.Com Content Network
Leuprorelin is marketed by Bayer AG under the brand name Viadur, [7] by Tolmar under the brand names Eligard and Fensolvi, [5] [6] and by TAP Pharmaceuticals (1985–2008), by Varian Pharmed( Previously named Varian Darou Pajooh) under the brand name Leupromer and Abbott Laboratories (2008–present) under the brand name Lupron.
A depot injection, also known as a long-acting injectable (LAI), is a term for an injection formulation of a medication which releases slowly over time to permit less frequent administration of a medication.
TAP Pharmaceuticals was formed in 1977 as a joint venture between the two global pharmaceutical companies, Abbott Laboratories and Takeda Pharmaceutical Co. and was dissolved in 2008; its two most lucrative products were proton-pump inhibitor lansoprazole (Prevacid) and the prostate cancer drug, leuprorelin (Lupron). [1]
Lupron Depot: This is a drug delivery device that helps treat prostate cancer and has been used to treat other types of similar cancers. It is also known as leuprorelin or leuprolide. PLGA is used as a key component in this drug, in the form of microparticles to deliver the drug into the body over a period of 1 week to 6 months. [15]
Medroxyprogesterone acetate is the generic name of the drug and its INN Tooltip INN, USAN Tooltip United States Adopted Name, BAN Tooltip BANM, and JAN Tooltip Japanese Accepted Name, while medrossiprogesterone is the DCIT Tooltip Denominazione Comune Italiana and médroxyprogestérone the DCF Tooltip Dénomination Commune Française of its ...
We researched over 40 hair regrowth products for men, rating each based on ingredients, efficacy, easy application methods, safety, success rate and reviews from firsthand users.
Bicalutamide is used primarily in the treatment of early and advanced prostate cancer. [1] It is approved at a dosage of 50 mg/day as a combination therapy with a gonadotropin-releasing hormone analogue (GnRH analogue) or orchiectomy (that is, surgical or medical castration) in the treatment of stage D2 metastatic prostate cancer (mPC), [2] [3] and as a monotherapy at a dosage of 150 mg/day ...
Oral tablet products with the same brand names of Klimanosid and Klimanosid R, containing methylestradiol and methyltestosterone, with and without reserpine, were marketed around the same time as Klimanosid-R Depot, and should not be confused with the injectable formulation. [8] [2] [9